Wordt geladen...
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Doxorubicin (DOX) is one of the most widely used and successful antitumor drugs, but its cumulative and dose-dependent cardiac toxicity has been the major concern of oncologists in cancer therapeutic practice for decades. With the increasing population of cancer survivals, there is a growing need to...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2809808/ https://ncbi.nlm.nih.gov/pubmed/19866340 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00005-009-0051-8 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|